T-cell allorecognition: a case of mistaken identity or deja vu?

被引:41
作者
Archbold, Julia K. [1 ]
Macdonald, Whitney A. [1 ]
Burrows, Scott R. [2 ]
Rossjohn, Jamie [1 ]
McCluskey, James [3 ]
机构
[1] Monash Univ, Prot Crystallog Unit, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia
[2] Queensland Inst Med Res, Cellular Immunol Lab, Brisbane, Qld 4029, Australia
[3] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia
基金
澳大利亚研究理事会; 英国医学研究理事会;
关键词
D O I
10.1016/j.it.2008.02.005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T cells bearing alpha beta T-cell receptors (TCRs) are selected by a subset of peptide-laden major histocompatibility (pMHC) molecules in the thymus and in the periphery and therefore are restricted to recognising host or 'self' MHC molecules. Nevertheless, T cells are inherently cross-reactive and often react with 'foreign' allogeneic MHC molecules (direct T-cell alloreactivity), manifested clinically as organ transplant rejection. Although the basis of T-cell alloreactivity has remained a puzzle to immunologists for decades, studies on alloreactive TCRs have begun to shed light on the basic mechanisms underpinning this 'mistaken identity'. Here we review recent advances in the field, focusing on structural and cellular studies, showing that alloreactivity may sometimes result from cross-reactivity without molecular mimicry and at other times may result directly from TCR interactions with allogeneic pMHC surfaces that mimic the cognate ligand.
引用
收藏
页码:220 / 226
页数:7
相关论文
共 72 条
[1]   Allorecognition and the alloresponse: clinical implications [J].
Afzali, B. ;
Lechler, R. I. ;
Hernandez-Fuentes, M. P. .
TISSUE ANTIGENS, 2007, 69 (06) :545-556
[2]   Alloreactivity between disparate cognate and allogeneic pMHC-I complexes is the result of highly focused, peptide-dependent structural mimicry [J].
Archbold, Julia K. ;
Macdonald, Whitney A. ;
Miles, John J. ;
Brennan, Rebekah M. ;
Kjer-Nielsen, Lars ;
McCluskey, James ;
Burrows, Scott R. ;
Rossjohn, Jamie .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (45) :34324-34332
[3]  
Auchincloss Hugh Jr., 1993, P1099
[4]   HLA-A2 SUBTYPES ARE FUNCTIONALLY DISTINCT IN PEPTIDE BINDING AND PRESENTATION [J].
BAROUCH, D ;
FRIEDE, T ;
STEVANOVIC, S ;
TUSSEY, L ;
SMITH, K ;
ROWLANDJONES, S ;
BRAUD, V ;
MCMICHAEL, A ;
RAMMENSEE, HG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (06) :1847-1856
[5]   HIGH DETERMINANT DENSITY MAY EXPLAIN THE PHENOMENON OF ALLOREACTIVITY [J].
BEVAN, MJ .
IMMUNOLOGY TODAY, 1984, 5 (05) :128-130
[6]   CD8 EXPRESSION ALTERS THE FINE SPECIFICITY OF AN ALLOREACTIVE MHC CLASS-I-SPECIFIC T-HYBRIDOMA [J].
BLOK, R ;
MARGULIES, DH ;
PEASE, L ;
RIBAUDO, RK ;
SCHNECK, J ;
MCCLUSKEY, J .
INTERNATIONAL IMMUNOLOGY, 1992, 4 (04) :455-466
[7]   The CDR3 regions of an immunodominant T cell receptor dictate the 'energetic landscape' of peptide-MHC recognition [J].
Borg, NA ;
Ely, LK ;
Beddoe, T ;
Macdonald, WA ;
Reid, HH ;
Clements, CS ;
Purcell, AW ;
Kjer-Nielsen, L ;
Miles, JJ ;
Burrows, SR ;
McCluskey, J ;
Rossjohn, J .
NATURE IMMUNOLOGY, 2005, 6 (02) :171-180
[8]   Have we cut ourselves too short in mapping CTL epitopes? [J].
Burrows, SR ;
Rossjohn, J ;
McCluskey, J .
TRENDS IN IMMUNOLOGY, 2006, 27 (01) :11-16
[9]   Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: Degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity [J].
Burrows, SR ;
Silins, SL ;
Khanna, R ;
Burrows, JM ;
Rischmueller, M ;
McCluskey, J ;
Moss, DJ .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (07) :1726-1736
[10]   AN ALLORESPONSE IN HUMANS IS DOMINATED BY CYTOTOXIC T-LYMPHOCYTES (CTL) CROSS-REACTIVE WITH A SINGLE EPSTEIN-BARR-VIRUS CTL EPITOPE - IMPLICATIONS FOR GRAFT-VERSUS-HOST DISEASE [J].
BURROWS, SR ;
KHANNA, R ;
BURROWS, JM ;
MOSS, DJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (04) :1155-1161